How UTX Mutation Affects Pancreatic Cancer Progression
Author Information
Author(s): Shen Xiao-hua, Xiong Shu-ping, Wang Sheng-peng, Lu Shan, Wan Yi-ye, Zhang Hui-qing
Primary Institution: Jiangxi Cancer Hospital
Hypothesis
This study aimed to explore how UTX mutation would affect its related function in pancreatic cancer.
Conclusion
The UTX mutant weakens the antitumor effect of wild-type UTX in pancreatic cancer by inhibiting G0S2 expression and activating the Toll-like signaling pathway.
Supporting Evidence
- Exome sequencing revealed a UTX missense mutation in 75% of pancreatic cancer samples.
- Wild-type UTX significantly inhibited cell proliferation and migration in pancreatic cancer cells.
- G0S2 was identified as a key target gene for UTX, with its expression significantly increased by wild-type UTX.
Takeaway
Scientists found that a change in a gene called UTX makes it harder for the body to fight pancreatic cancer, which is a very serious illness.
Methodology
Exome sequencing, MTT, transwell, and colony formation assays were performed to analyze cellular functions and mechanisms in pancreatic cancer cells.
Limitations
The missense mutation of UTX in pancreatic cancer is not present in all samples, suggesting non-universal mutations in this region.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website